DEPARTMENT OF LABOR

Employment and Training Administration

TA-W-85,930

TEVA PHARMACEUTICALS USA, INC.
A SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD.
KUTZTOWN, PENNSYLVANIA

Certification Regarding Eligibility
To Apply for Worker Adjustment Assistance

In accordance with Section 223 of the Trade Act of 1974, as
amended ("Act"), 19 U.S.C. § 2273, the Department of Labor
herein presents the results of an investigation regarding
certification of eligibility to apply for worker adjustment
assistance.
The group eligibility requirements for workers of a firm
under Section 222(a) of the Act, 19 U.S.C. § 2272(a), are
satisfied if the following criteria are met:
(1) a significant number or proportion of the
workers in such workers' firm have become totally or
partially separated, or are threatened to become
totally or partially separated;
(2)(B)(i)(I) there has been a shift by the workers'
firm to a foreign country in the production of
articles or supply of services like or directly
competitive with those produced/supplied by the
workers' firm; OR
(II) there has been an acquisition from a
foreign country by the workers' firm of
articles/services that are like or directly
competitive with those produced/supplied by
the workers' firm; AND
(ii) the shift/acquisition must have contributed
importantly to the workers' separation or
threat of separation.

The investigation was initiated in response to a petition
filed on April 8, 2015 by three workers on behalf of Teva
Pharmaceuticals USA, Inc., a subsidiary of Teva Pharmaceutical
Industries Ltd., Kutztown, Pennsylvania (herein known as "Teva
Pharmaceuticals USA, Inc."). The subject workers' firm is
engaged in activities related to the distribution of specialty
and generic pharmaceutical products produced at Teva
Pharmaceuticals USA, Inc., Sellersville, Pennsylvania.
During the course of the investigation, information was
collected from the workers' firm and the petitioner.
Section 222(a)(1) has been met because a significant
number or proportion of the workers in such workers' firm have
become totally or partially separated, or are threatened to
become totally or partially separated.
Section 222(a)(2)(B) has been met because the workers'
firm has acquired from a foreign country articles like or
directly competitive with the generic pharmaceutical products
produced by the firm which contributed importantly to worker
group separations at Teva Pharmaceuticals USA, Inc., Kutztown,
Pennsylvania.
Conclusion
After careful review of the facts obtained in the
investigation, I determine that workers of Teva Pharmaceuticals
USA, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd.,
Kutztown, Pennsylvania, who are engaged in activities related to
the distribution of specialty and generic pharmaceutical
products meet the worker group certification criteria under
Section 222(a) of the Act, 19 U.S.C. § 2272(a). In accordance
with Section 223 of the Act, 19 U.S.C. § 2273, I make the
following certification:
"All workers of Teva Pharmaceuticals USA, Inc., a
subsidiary of Teva Pharmaceutical Industries Ltd.,
Kutztown, Pennsylvania, who became totally or partially
separated from employment on or after April 7, 2014 through
two years from the date of certification, and all workers
in the group threatened with total or partial separation
from employment on the date of certification through two
years from the date of certification, are eligible to apply
for adjustment assistance under Chapter 2 of Title II of
the Trade Act of 1974, as amended."
Signed in Washington, D.C. this 14th day of March 2016.

/s/Hope D. Kinglock
______________________________
HOPE D. KINGLOCK
Certifying Officer, Office of
Trade Adjustment Assistance